| 摘要 |
The disclosure herein provides the compounds of Formulas 1 and its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, transdermal administration, and/or injection. Such compositions may be used for the treatment of metabolic conditions, cystinosis, non-alcoholic Steatohepatitis, hypertriglyceridemia, and/or neurodegenerative disorders, and/or their associated complications. |
| 主权项 |
1. A method of treating at least one of a cardiovascular disease, a hepatic disease, a genetic disorder, and a metabolic disorder comprising:
administering the compound of Formula 1 to a patient suffering from at least one of a cardiovascular disease, a hepatic disease, a genetic disorder, and a metabolic disorder. |
